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ABSTRACT
Pancreas preservation by cold storage using University of Wisconsin solution was the
mainstay method used for pancreas transplantation during the past 2 decades. Other
solutions, such as HTK, Celsior, and SCOT 15, could not demonstrate any advantage for
short preservation periods. But the advent of clinical islet transplantation and the larger
use of controlled non–heart-beating donors have prompted the transplantation commu-
nity to develop methods for increasing pancreas graft quality while preventing ischemic
reperfusion damages. Oxygenation by 1- or 2-layer methods during pancreas preservation,
as well as the use of perfluorocarbons, might increase the islet yield. Based on the former
methods, there is a renewed interest in machine perfusion and oxygenation in pancreas




cOutcome after whole organ pancreas transplantation hasconsistently improved over the past 20 years; islet
ransplant results are also improving steadily.1 The reasons are
ultifactorial, including improved immunosuppression,2 pro-
hylaxis against infections and thrombosis,3 and modifications
in surgical4 and islet preparation techniques.5 In addition,
mprovements in organ preservation have undoubtedly had a
ignificant impact on outcome.5,6 That has been achieved by
cooling the pancreas organ down to 4–8°C and maintaining a
milieu of reduced metabolism at low temperatures. But the
pancreas has certain unique anatomic aspects. First, when
procured for a whole-organ transplant, the pancreas is taken
with a segment of duodenum. The bowel (duodenum) is more
prone to cold ischemic injury than other abdominal organs.
Second, the pancreas is a low-flow organ, as compared with
the kidney, so it is more susceptible to barotraumas from
aggressive cold perfusion after the aorta is cross-clamped.
Therefore, preservation tools and methods for whole-organ
pancreas transplantation are not valid for islet transplant
preparations. Indeed, cold storage may be adequate for pres-
ervation before pancreas transplants, but insufficient when
pancreases are processed for islets or when expanded-criteria
donors are used. Supplementation of cold storage solutions
with cytoprotective agents and machine perfusion may im-
prove pancreas and islet transplant outcomes in the future.7
PANCREAS PRESERVATION FOR TRANSPLANTATION
The 2 main methods used for experimental and clinical
pancreas (organ) preservation are static cold storage and
machine perfusion.7 The hypothermic pulsatile machine
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3398erfusion technique, originally developed by Carrel and
ately popularized by Belzer,8 has been widely used for
clinical kidney transplants but not for clinical pancreas
preservation.
Early experiments with canine segmental grafts, reported
by Florack et al,9 demonstrated that failure rates with
machine perfusion were 30% at 24 hours and 40% at 48
hours. There were no failures at 24 and 48 hours with cold
storage. These results, along with the complexities associ-
ated with machine perfusion of the pancreas, have made
cold storage the preferred and most widely used method for
pancreas preservation.7
For cold storage of pancreas transplants, the first solu-
tions used were Collins,10,11 Sacks,12 and Euro-Collins.13
But University of Wisconsin solution (UW)14,15 became
nd has been the standard preservation solution for pan-
reas transplantation for almost 20 years.7 Recently, multi-
ple reports have suggested that other preservation solutions
may be effective alternatives to UW (Table 1).
Studies comparing histidine-tryptophan-ketoglutarate
(HTK) solution with UW have demonstrated similarities
between both solutions in the context of low-to-moderate
flush volume and short cold ischemia time (10 h) for
HTK.16–19 In contrast, other studies in pancreata flushed
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PANCREAS PRESERVATION 3399with HTK found a higher incidence of postoperative com-
plications, including graft pancreatitis, use of octreotide,
and a decreased rate of insulin independence at hospital
discharge.20–22
Celsior, an extracellular, low-viscosity preservation solu-
tion originally designed for heart transplantation, has also
been used for experimental pancreas preservation with
controversial results: effective alternative to UW according
to Baldan et al,23 versus increased ischemia-reperfusion
injury according to Uhlmann et al.24 For other organs, such
as lung25 and liver,26–28 Celsior solution gave similar clini-
cal results. The first prospective randomized study compar-
ing UW and Celsior for clinical pancreas transplants was
reported by Boggi et al,29 demonstrating similar safety
profiles for pancreas preservation. That was also reported
by Manrique et al30: 2-year graft survival rates, pancreas
eakage rates, and clinical graft pancreatitis rates were
imilar using either solution. That is also true for kidney
reservation.31
A new preservation solution, SCOT 15 (Solution de
Conservation d’Organes et de Tissus), which contains an
extracellular ionic composition including polyethylene gly-
col (PEG) as a colloid, was recently used by Hauet et al,32
for experimental organ preservation, but clinical data for
pancreas preservation are still lacking.
PANCREAS PRESERVATION FOR ISLET
TRANSPLANTATION
UW has also been used since the 1980s as the pancreas
preservation solution for clinical islet transplants.33 After
ther preservation solutions became available, Salehi et al34
reported that islet yields from human pancreases preserved
in HTK or UW were equivalent. Another study by Hubert
et al35 demonstrated that the islet isolation yields from
ancreata preserved with Celsior were 2.1-fold lower than
hose obtained with UW. That study suggests that colloid-
Table 1. Preservation Solutions
Component (mmol/L) EC UW HTK Celsior SCOT 15
Na 10 28 15 100 143
K 113.4 125 18 15 5
Ca 0.015 0.26 1.7








PEG 20 15 g/L
Viscosity 1.18 3.156 1.15 1.05
Abbreviations: EC, EuroCollins; UW, University of Wisconsin; HTK, histidine-
tryptophane-ketoglutarate; SCOT, Solution de Conservation d’Organes et de
Tissus.ree preservation solutions might be suboptimal for pan-reas perfusion and cold storage before islet isolation and
ransplantation.
In contrast, Giraud et al36 demonstrated the possibility of
clinical application and advantages of using SCOT, which
could increase islet yield and reduce graft immunogenicity
in pancreatic islet transplantation. Using SCOT, the same
authors eventually improved the islet isolation process from
pancreata of non–heart-beating donors37 in a murine
model.
Based on that early experience, there is a consensus among
the major islet transplantation centers that islet yields and
quality can be improved with better pancreas procurement
techniques and by the use of cold-preservation techniques that
are not necessarily needed for whole-pancreas transplants.7
The 2-layer method (TLM) for pancreas preservation is an
example of a technique for improving islet yield and quality
by increasing pancreas oxygenation during preservation.
Based on several studies,38–40 TLM has been widely used
by islet transplant centers worldwide, but the mechanisms
by which it improves human islet yield and quality are not
yet fully understood. It has been suggested by Matsuda et
al41 that TLM cold storage protects isolated islets against
apoptosis through the mitochondrial pathway. Noguchi et
al,42 with a pig model, reported that the islet yield from
pancreata preserved with TLM and a modified so-called
classic solution was significantly higher than with TLM
using UW. They hypothesized that their own solution is
less likely to inhibit collagenase activity than UW.43
Therefore, TLM could be a promising technique for both
pancreas and islet transplantation44 while using other
reservation methods.
The basic principle of TLM is the use of a cold storage
olution, mainly UW, in combination with an oxygen carrier
olution, the perfluorocarbons (PFC), which have a higher
pecific gravity. Therefore the PFC solution settles at the
ottom and the UW is above it. The pancreas is suspended
t the interface of the 2 solutions (Fig 1). Oxygenation of
he PFC for 40 minutes before pancreas placement is
ufficient to maintain adequate O2 concentrations for up to
4 hours. The oxygenation must be done with a gaseous
ressure of 10–12 mm Hg and a flow rate of 50–100
L/min. After that period, pancreata can be transported
ithout the oxygenating apparatus. Moreover, it has been
hown that maintaining the temperature of the medium at
°C rather than 4°C results in superior islet function.6 The
beneficial role of oxygenation for improving pancreas qual-
ity and islet isolation was also experimentally demonstrated
by Hackl et al45 using simple preoxygenation of different
reservation solutions (UW, HTK, Celsior) and by Scott et
l using persufflation.46
Therefore, using the 1- and two-layer methods, using
perfluorocarbons, which are inert solutions with a high
capacity for dissolving oxygen, or oxygenation with other
tools, these methods have been proving to be successful for
pancreas preservation by cold storage. Taking into account
that PFCs can be formulated as an emulsion, there is a huge



















3400 SQUIFFLET, LEDINH, DE ROOVER ET ALmachine perfusion or as simple flush solution.47 Indeed,
aylor et al48 reported that islet isolation from juvenile
orcine pancreas after 24-hour hypothermic machine per-
usion (HMP) preservation can be successfully achieved;
MP is well tolerated, leading to moderate edema but no
oss of function of the harvested islets. Moreover, the
dema appears to aid in enzymatic digestion, producing a
reater yield and purity of islets compared with pancreas
ubjected to 24 hours of static cold storage. In parallel,
arcz et al49 have developed a model of machine perfusion
or porcine pancreata that is simple, reliable, and protects
raft histopathologic integrity. The model can be used in
urther studies to improve the quality of pancreas preser-
ation and to assess the condition of and improve the
iability of borderline pancreatic grafts.
CONCLUSION
With the number of pancreas transplants increasing and the
advent of clinical islet transplants, a significant shortage of
pancreata will appear soon. Better preservation methods
than just cold storage of donor pancreata will be needed.
Because controlled non–heart-beating donors (NHBDs)
may be a potential source for pancreata, other preservation
methods might be foreseen. Indeed, with NHBDs, signifi-
cant ischemic damage and postoperative complications
might especially occur with prolonged preservation using
cold storage.50,51 The use of TLM has shown promise in
rolonging clinical pancreas preservation times and amelio-
ating warm ischemic insult.6
Therefore, there is an urgent need to get access to the
TLM technology not only for pancreas preservation for islet
transplantation, but also for pancreas transplantation. The
machine perfusion technique is also a pancreas preserva-
Fig 1. The 2-layer method: University of Wisconsin (UW) solu-
tion is above and perfluorocarbons (PFC) solution below.tion method that needs to be reevaluated in the light of newechnologies using other perfusion fluids, temperatures,
nd oxygenation for conditioning the pancreatic graft.
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